CO NECTAR
LIVE

Serial Number

98911999

Owner

HoneyBear Biosciences, Inc.

Attorney

Simone Chen

Filing Date

Dec 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CO NECTAR Trademark

Serial Number: 98911999

CO NECTAR is a trademark filed by HoneyBear Biosciences, Inc. on December 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

HoneyBear Biosciences, Inc.

3F., No.99, Ln. 130, Sec. 1 Academia Rd.
Taipei City 115021 , TW

Entity Type: 03

Trademark Details

Filing Date

December 19, 2024

Registration Date

Not Registered

Published for Opposition

July 15, 2025

Goods & Services

Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for medical purposes; chemico-pharmaceutical preparations; vaccines; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for pharmaceutical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease

Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing.

Filing History

TEAS PETITION TO AMEND BASIS RECEIVED
May 4, 2026 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 4, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 24, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 14, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2025 CNEA
ASSIGNED TO EXAMINER
Jun 5, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 28, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2025 NWOS
NEW APPLICATION ENTERED
Dec 19, 2024 NWAP